3 Results for "

Androgen Receptor Splice Variant-7

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Androgen Receptor Splice Variant-7" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-148771
CAS No.: 2488296-74-6
Purity:  99.79%
Synonyms: PROTAC AR-V7 degrader-2
Research Areas:  

Cancer

MTX-23 is a PROTAC degrader targeting androgen receptor splice variant 7 (AR-V7) and full-length androgen receptor (AR-FL), with DC50 values of 0.37 μM and 2 μM, respectively. MTX-23 binds to the DNA-binding domains of AR-V7 and AR-FL, recruits the VHL E3 ubiquitin ligase (E3 ubiquitin ligase) and induces their degradation. MTX-23 reduces the proliferation of prostate cancer cells, promotes their apoptosis (apoptosis), and also inhibits tumor growth in mouse models. MTX-23 can be used for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-149433
CAS No.: 3042820-12-9
Purity:  99.93%
Research Areas:  

Cancer

BWA-522 is an orally active PROTAC degrader targeting full-length androgen receptor (AR-FL) and androgen receptor splice variant 7 (AR-V7). BWA-522 antagonizes the N-terminal domain (AR-NTD) of the androgen receptor, suppresses AR downstream signaling proteins and induces cancer cells apoptosis. BWA-522 inhibits tumor growth in LNCaP xenograft mouse model. BWA-522 can be used for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-177694
CAS No.: 2798907-41-0
Research Areas:  

Cancer

PROTAC AR Degrader-11 is a potent androgen receptor and androgen receptor splice variant-7 PROTAC degrader. PROTAC AR Degrader-11 shows potent cytotoxicity against both CWR22RV1 cells and VCaP cells. PROTAC AR Degrader-11 can be used in prostate cancer research .
loading...
    loading...